Emtricitabine (process-iv)
Generic Name: emtricitabine (process-iv)
Dosage form: POWDER. Active ingredients: EMTRICITABINE (50 kg/50kg). Category: BULK INGREDIENT.
Overview
Dosage form: POWDER. Active ingredients: EMTRICITABINE (50 kg/50kg). Category: BULK INGREDIENT.
Dosage
Available as powder.
Related Medications
Iodamide Meglumine
iodamide meglumine
Manufactured by BRACCO. Dosage form: INJECTABLE. Route: INJECTION. Active ingredients: IODAMIDE MEGLUMINE (24%). Application: NDA017903.
Vortioxetine Hydrobromide
vortioxetine hydrobromide
Dosage form: POWDER. Active ingredients: VORTIOXETINE HYDROBROMIDE (1 kg/kg). Category: BULK INGREDIENT.
Axicabtagene Ciloleucel
axicabtagene ciloleucel
CD19-directed Chimeric Antigen Receptor [EPC]
11 DESCRIPTION YESCARTA (axicabtagene ciloleucel) is a CD19-directed genetically modified autologous T cell immunotherapy. To prepare YESCARTA, a patient's own T cells are harvested and genetically modified ex vivo by retroviral transduction to express a chimeric antigen receptor (CAR) comprising a murine anti-CD19 single chain variable fragment (scFv) linked to CD28 and CD3-zeta co-stimulatory domains.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.